Molecular Cytogenetics Market Boosting Due To Increasing Importance Molecular Cytogenetic In Crop Improvement Till 2025: Grand View Research, Inc.
The
global molecular cytogenetics market size is expected to
reach USD 3. 8 billion by 2025, according to a new report by Grand View
Research, Inc., exhibiting a 10.4% CAGR during the forecast period. Mapping of
human genome, coupled with continuous technological advancements in cytogenetic
techniques, has enabled researchers to gain insight into the disease-causing
mechanism at a genomic as well as cellular level. Development in molecular
technologies has helped in bridging the gap between molecular biology and
cytogenetics, which was not possible using conventional cytogenetic
techniques.
There
is a continuous growth in awareness, and consequent adoption, of genetic tests
for disease prognosis. These tests also help in designing further treatment
regimes for widespread chromosomal abnormalities. This is sure to boost market
growth.
Incorporation
of high throughput sequencers in cytogenetic analysis is expected to
significantly enhance market growth in the coming years. A number of
researchers and scientists have begun converging cytogenetics laboratories with
NGS as they complement each other. Hence, with exponential decline in
sequencing price, this market is expected to grow at a lucrative pace.
However,
ambiguous regulatory and reimbursement scenario in certain regions pertaining
to implementation of genetic tests is expected to hamper the adoption of
molecular cytogenetic techniques to a certain extent.
Browse full
research report on Molecular Cytogenetics Market: www.grandviewresearch.com/industry-analysis/molecular-cytogenetics-market
Further
Key Findings from the Study Suggests:
- Oncology held the largest share in the market
in 2016 owing to the ability of CGH technology to facilitate in-depth
studies for cancer etiology
- Use of molecular cytogenetics in personalized
medicine development is expected to grow lucratively during the forecast
period. This is majorly due to a continuous shift toward targeted
therapies for effective disease management
- Requirement of consumables in the entire
cytogenetics process is attributive for the largest share of this product
category
- Ongoing research projects for developing
treatment regimen of different genetic conditions have allowed clinical
and research laboratories to gain a significant share in the market
- Pharmaceutical and biotech companies are
expected to be a key source of revenue in the coming years. This is mainly
because a number of pharmaceutical companies have expanded their business
in the field of personalized medicine
- Illumina, Inc.; Agilent Technologies, Inc.;
Abbott; Bio-Rad Laboratories, Inc.; and Oxford Gene Technology are some
prominent companies in the market. They are involved in development and
commercialization of cytogenetics techniques
- Some major service providers are Weill Cornell
Medicine; WiCell Research Institute, Inc.; ARUP Laboratories; and
Integrated Systems Engineering S.r.l.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global molecular cytogenetics
market on the basis of application, product, end use, technology, and region:
Molecular
Cytogenetics Application Outlook (Revenue, USD Million, 2014 - 2025)
- Genetic
Disorders
- Oncology
- Personalized
Medicine
- Other
Applications
Molecular
Cytogenetics Product Outlook (Revenue, USD Million, 2014 - 2025)
- Instruments
- Consumables
- Software
& Services
Molecular
Cytogenetics End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Clinical
& Research Laboratories
- Hospitals
& Pathology Laboratories
- Academic
Research Institutes
- Pharmaceutical
and Biotechnology Companies
- Other
End-use
Molecular
Cytogenetics Technology Outlook (Revenue, USD Million, 2014 - 2025)
- Comparative
Genomic Hybridization
- Array-based
comparative genomic hybridization
- Standard
comparative genomic hybridization
- Fluorescence
In Situ Hybridization (FISH)
- Immunohistochemistry
- Karyotyping
- Spectral
karyotyping
- Virtual
karyotyping
- Other
Techniques
Molecular
Cytogenetics Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Middle
East & Africa
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-molecular-cytogenetics-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment